BriaCell advances melanoma vaccine candidate to genetic engineering milestone

Go back to BriaCell advances melanoma vaccine candidate to genetic engineering milestone
(NASDAQ: BCTX) Delayed: 3.58 +0.01 (0.28%)
Previous Close $3.57    52 Week High
Open $3.57    52 Week Low
Day High $3.62    P/E N/A 
Day Low $3.42    EPS
Volume 145,171